Receptos LLC
(NASDAQ : RCPT)

( )
RCPT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.01%178.750.7%$1158.93m
LLYEli Lilly & Co. -0.24%369.551.1%$1134.53m
MRKMerck & Co., Inc. -0.03%109.800.7%$1032.95m
PFEPfizer Inc. -0.47%50.900.9%$987.15m
ABBVAbbVie, Inc. 0.13%161.791.9%$867.17m
BMYBristol-Myers Squibb Co. 0.01%80.881.1%$771.78m
AZNAstraZeneca Plc -0.12%68.261.0%$357.70m
HZNPHorizon Therapeutics Plc 2.90%103.815.4%$318.19m
IDXXIDEXX Laboratories, Inc. 0.00%439.173.9%$229.98m
CTLTCatalent, Inc. -0.46%52.001.9%$212.69m
GSKGSK Plc 0.33%35.150.3%$190.37m
NVSNovartis AG -0.28%89.560.2%$185.81m
NVONovo Nordisk A/S 0.04%126.170.1%$172.87m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%220.258.0%$161.43m
RGENRepligen Corp. 0.00%188.176.7%$134.32m

Company Profile

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.